Integrating Computational Phenotyping with Next-Generation Pharmacology
This two-day, invitation-only meeting convenes leading academic and industry researchers to examine how schizophrenia may be redefined through advances in computational phenotyping and next-generation pharmacology. By integrating brain, behavioral, and biological data, the symposium aims to foster collaboration among computational scientists, clinical researchers, and industry partners across three thematic areas:
- Next-generation pharmacology for schizophrenia
- Computational approaches to patient stratification
- Mechanistic circuit neuroscience